These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1527088)

  • 21. A simple and rapid method to study the association of the contact proteins of blood coagulation.
    Katcher HL; Samuel M; Villanueva GB
    Thromb Res; 1992 Dec; 68(6):443-50. PubMed ID: 1341054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).
    Griffin JH; Beretta G
    Adv Exp Med Biol; 1979; 120B():39-51. PubMed ID: 517240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The function of the heavy and light chain of human plasma kallikrein in the activation of factor XII.
    Rosing J; Tans G; Griffin JH
    Adv Exp Med Biol; 1986; 198 Pt B():27-34. PubMed ID: 3492870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
    Tsuda H; Miyata T; Iwanaga S; Yamamoto T
    Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
    Maas C; Govers-Riemslag JW; Bouma B; Schiks B; Hazenberg BP; Lokhorst HM; Hammarström P; ten Cate H; de Groot PG; Bouma BN; Gebbink MF
    J Clin Invest; 2008 Sep; 118(9):3208-18. PubMed ID: 18725990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.
    Scott CF; Colman RW
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11189-93. PubMed ID: 1454798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1985 Jul; 24(15):4124-30. PubMed ID: 3876845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of human Hageman factor by a leukocytic protease.
    Newball HH; Revak SD; Cochrane CG; Griffin JH; Lichtenstein LM
    Adv Exp Med Biol; 1979; 120B():139-51. PubMed ID: 517231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain.
    Rosing J; Tans G; Griffin JH
    Eur J Biochem; 1985 Sep; 151(3):531-8. PubMed ID: 3875484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
    Wiggins RC
    Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).
    Morrison DC; Cochrane CG
    J Exp Med; 1974 Sep; 140(3):797-811. PubMed ID: 4378413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of beta 2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation.
    Schousboe I; Rasmussen MS
    Int J Biochem; 1988; 20(8):787-92. PubMed ID: 3169363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoactivation of human blood coagulation factor XII on dextran derivatives of different molecular weight.
    Tazi S; Tans G; Hemker HC; Nigretto JM
    Thromb Res; 1992 Sep; 67(6):665-76. PubMed ID: 1279836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purified factor XII has a higher specific activity than the parent molecule in plasma.
    Wuillemin WA; Furlan M; Huber I; Lämmle B
    Thromb Haemost; 1991 Feb; 65(2):169-73. PubMed ID: 2053104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-chain factor XII exhibits activity when complexed to polyphosphate.
    Engel R; Brain CM; Paget J; Lionikiene AS; Mutch NJ
    J Thromb Haemost; 2014 Sep; 12(9):1513-22. PubMed ID: 25039405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.